Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashi Badloe

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMC Cancer|July 3, 2023
Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGSIanthe A E M van Belzen, Casey Cai, Marc van Tuil, et al.
Cancers|October 14, 2022
Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms TumorsIanthe A E M van Belzen, Marc van Tuil, Shashi Badloe, et al.
Cell Genomics|October 15, 2024
Complex structural variation is prevalent and highly pathogenic in pediatric solid tumorsIanthe A E M van Belzen, Marc van Tuil, Shashi Badloe, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMC Cancer|July 3, 2023
Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGSIanthe A E M van Belzen, Casey Cai, Marc van Tuil, et al.
Cancers|October 14, 2022
Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms TumorsIanthe A E M van Belzen, Marc van Tuil, Shashi Badloe, et al.
Cell Genomics|October 15, 2024
Complex structural variation is prevalent and highly pathogenic in pediatric solid tumorsIanthe A E M van Belzen, Marc van Tuil, Shashi Badloe, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Pageof 1